Adverse drug reactions (ADRs): Managing and Monitoring at 199 Hospital

Tóm tắt

On time detection of Adverse Drug Reactions (ADRs) helps avoid the harmful effects to patients, and promptly prevent mishaps or disasters to our health care. To assist in monitoring the safety in the use of drugs for patients, and providing maximum data to the National Center for DI&ADR on the drug safety of Phase 4 (the drugs are widely used in the community), clinical pharmacists have monitored ADRs actively instead of waiting for clinical reports. A cross-sectional description study was done by interview, review profiles, examine inpatients randomly at any time of the treatment (priority to choose patients with complex pharmacotherapy or high-risk drugs causing adverse reactions). A total of 455 interviews, examinations, and follow-ups of 15 ADRs cases were actively exploited by pharmacists (3.3%). Harmful reactions are also recorded in most specialties. The first rate was acute reaction (47%, 7 cases), the second rate was sub -acute reaction (33%, 5 cases), and the delayed reaction accounted for at least (20%, 3 cases). There are 14 drugs that are suspect or certainly related to adverse reactions, 8 of these are high-risk drugs on A-PINCH list (accounting for 57%). Proactive ADRs monitoring is necessary to minimize the risks for patients. Clinical pharmacists should get involved in the process and follow through. Aside from providing health care providers with frequent trainings to keep them with the up-to-date information needed, an improvement of prescription software to minimize ADRs should be applied.